I wore the world's first HDR10 smart glasses TCL's new E Ink tablet beats the Remarkable and Kindle Anker's new charger is one of the most unique I've ever seen Best laptop cooling pads Best flip ...

Merck said on Monday it would split its business into two, creating ⁠a distinct division for its cancer franchise led by blockbuster drug Keytruda while grouping its non-oncology treatments separately ...

Thank you, John, and thanks to everyone for joining our call. After a thorough search for a permanent CEO by a leading executive search firm, the board concluded that, among other things, maintaining ...

Merck MRK-N said on Monday it would split its human-health business into two units, creating a division for its cancer franchise led by blockbuster drug Keytruda while grouping its non-oncology ...

Feb 23 (Reuters) - Merck is splitting its human-health business into two ‌divisions to offset pressures ‌related to the loss of patent for its top-selling drug Keytruda, the Wall Street Journal ...

Feb 23 (Reuters) - Merck said on ⁠Monday ⁠it would create a separate ⁠division for its cancer business, anchored by its top-selling drug Keytruda, as the U.S. drugmaker braces for the upcoming patent ...

Feb 23 (Reuters) - Merck said on Monday it will split its human-health business into two divisions, separating its blockbuster cancer franchise led by Keytruda from its non-oncology medicines. The ...

Will Kenton is an expert on the economy and investing laws and regulations. He previously held senior editorial roles at Investopedia and Kapitall Wire and holds a MA in Economics from The New School ...

ian MacLeod is a reporter at the Windsor Star. He has worked at eight newspapers, holding managing editor positions at four. His journalism career has taken him all over Ontario and to Saskatoon, ...

WASHINGTON (AP) — Gun rights and cannabis legalization are usually on opposite ends of the political spectrum, but both movements have brought about seismic shifts in the United States in recent ...